Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pituitary Neoplasms × lanreotide × Clear all

Phase

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Pituitary Neoplasms 1 Neuroendocrine Tumors in Lung 1 Neuroendocrine Tumors 1 Gigantism 1 Gastrointestinal Neoplasms 1 Carcinoid Tumor 1 Acromegaly 1

Interventions

pasireotide 2 lanreotide 1 Rosiglitazone 1 Pafolacianine 1 Endoscopic Mucosal Resection 1 Dexamethasone 1 Calcium Dobesilate 1 Cabergoline 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡